Author:
Abdullahi Sagiru Hamza,Uzairu Adamu,Shallangwa Gideon Adamu,Uba Sani,Umar Abdullahi Bello
Reference23 articles.
1. Global battle against cancer won't be won with treatment alone effective prevention measures urgently needed to prevent cancer crisis,2014
2. Chemo-informatics activity prediction, ligand based drug design, Molecular docking and pharmacokinetics studies of some series of 4, 6-diaryl-2-pyrimidinamine derivatives as anti-cancer agents;Abdullahi;Bull Natl Res Cent,2021
3. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study;El-Azab;Eur J Med Chem,2010
4. The anticancer activity of some novel 4-anilino quinazoline derivatives as tyrosine kinase (EGFR) inhibitor and the quantitative structure activity relationships;Tiwari;Int J Pharm Life Sci,2015
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Computer-aided discovery of novel SmDHODH inhibitors for schistosomiasis therapy: Ligand-based drug design, molecular docking, molecular dynamic simulations, drug-likeness, and ADMET studies;PLOS Neglected Tropical Diseases;2024-09-12
2. Ligand based-design of potential schistosomiasis inhibitors through QSAR, homology modeling, molecular dynamics, pharmacokinetics, and DFT studies;Journal of Taibah University Medical Sciences;2024-04
3. 3D-QSAR and Molecular Dynamics Study of Isoxazole Derivatives to Identify the Structural Requirements for Farnesoid X Receptor (FXR) Agonists;Molecules;2024-03-08
4. Computational design of quinoxaline molecules as VEGFR-2 inhibitors: QSAR modelling, pharmacokinetics, molecular docking, and dynamics simulation studies;Biocatalysis and Agricultural Biotechnology;2023-08
5. In-silico design of some pyrazolopyridine analogs as breast cancer inhibitors: QSAR modeling, molecular docking, MD simulation, and pharmacological features profiling;Journal of the Indian Chemical Society;2023-08